C84.7A Código faturável e específico Anaplastic large cell lymphoma, ALK-negative, breast

ICD-10-CM C84.7A identifies “Anaplastic large cell lymphoma, ALK-negative, breast” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Capítulo 2: Neoplasms

Instruções do código

Inclusion terms1

Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)

Use additional code3
  • code to identify:
  • breast implant status (Z98.82)
  • personal history of breast implant removal (Z98.86)

Instruções dos níveis superiores

Capítulos 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C84 · Mature T/NK-cell lymphomas

Excludes 11

personal history of non-Hodgkin lymphoma (Z85.72)

C84.7 · Anaplastic large cell lymphoma, ALK-negative

Excludes 11

primary cutaneous CD30-positive T-cell proliferations (C86.6-)

Referências do índice oficial

Referências do índice oficial (1)

Lymphoma(of) (malignant) (1)

Histórico oficial de conversão

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Datas de validade 2021-10-01

Atribuição anterior: C84.79

Histórico

Histórico do código

Última alteração registrada · FY2022

AlteradoSem alteração
FY2022

Válido a partir de

  • Adicionado

Anaplastic large cell lymphoma, ALK-negative, breast

Código de diagnóstico faturável

CDC/NCHS · FY2022

Todas as edições (11)

Todas as ediçõesVálido a partir deHistórico do código
FY20222021-10-01Adicionado
FY2022 · 04-012022-04-01Sem alteração tabular
FY20232022-10-01Sem alteração tabular
FY2023 · 04-012023-04-01Sem alteração tabular
FY20242023-10-01Sem alteração tabular
FY2024 · 04-012024-04-01Sem alteração tabular
FY20252024-10-01Sem alteração tabular
FY2025 · 04-012025-04-01Sem alteração tabular
FY20262025-10-01Sem alteração tabular
FY2026 · April2026-04-01Sem alteração tabular
FY20272026-10-01Sem alteração tabular

Esta entrada é um código completo na edição selecionada. A verificação da referência não estabelece adequação clínica nem garante reembolso.